Version 1
: Received: 15 October 2018 / Approved: 15 October 2018 / Online: 15 October 2018 (17:59:55 CEST)
How to cite:
Chamorro-Petronacci, C.; Pérez-Sayáns, M.; Padin-Iruegas, M.E.; Suarez-Peñaranda, J.M.; Lorenzo-Pouso, A.I.; Blanco-Carrion, A.; Garcia-Garcia, A. Association of miR-497-5p and miR-4417 Expression in Oral Squamous Cell Carcinoma and Clinical Parameters. Preprints2018, 2018100331. https://doi.org/10.20944/preprints201810.0331.v1
Chamorro-Petronacci, C.; Pérez-Sayáns, M.; Padin-Iruegas, M.E.; Suarez-Peñaranda, J.M.; Lorenzo-Pouso, A.I.; Blanco-Carrion, A.; Garcia-Garcia, A. Association of miR-497-5p and miR-4417 Expression in Oral Squamous Cell Carcinoma and Clinical Parameters. Preprints 2018, 2018100331. https://doi.org/10.20944/preprints201810.0331.v1
Chamorro-Petronacci, C.; Pérez-Sayáns, M.; Padin-Iruegas, M.E.; Suarez-Peñaranda, J.M.; Lorenzo-Pouso, A.I.; Blanco-Carrion, A.; Garcia-Garcia, A. Association of miR-497-5p and miR-4417 Expression in Oral Squamous Cell Carcinoma and Clinical Parameters. Preprints2018, 2018100331. https://doi.org/10.20944/preprints201810.0331.v1
APA Style
Chamorro-Petronacci, C., Pérez-Sayáns, M., Padin-Iruegas, M.E., Suarez-Peñaranda, J.M., Lorenzo-Pouso, A.I., Blanco-Carrion, A., & Garcia-Garcia, A. (2018). Association of miR-497-5p and miR-4417 Expression in Oral Squamous Cell Carcinoma and Clinical Parameters. Preprints. https://doi.org/10.20944/preprints201810.0331.v1
Chicago/Turabian Style
Chamorro-Petronacci, C., Andres Blanco-Carrion and Abel Garcia-Garcia. 2018 "Association of miR-497-5p and miR-4417 Expression in Oral Squamous Cell Carcinoma and Clinical Parameters" Preprints. https://doi.org/10.20944/preprints201810.0331.v1
Abstract
MicroRNAs are small non-coding RNAs that are implicated in several physiological processes such as cell development, proliferation, differentiation, apoptosis, immune response and angiogenesis. In the last couple of decades, several studies on miRNA profiling in OSCC have tried to associate miRNAs with clinical characteristics such as relapse, metastasis, and survival, however, the results have been found to vary considerably, sometimes even being contradictory. The main objective of our study was to analyse and verify miRNA expression in oral squamous cell carcinoma in a Spanish population. Second, we attempted to associate the identified deregulated miRNAs with molecular pathways. 8 Oral Squamous Cell Carcinoma patients and 8 healthy control samples were analysed by a microarray Affymetrix® miRNA 4.1 array plate and validated with 8 more cases using RT-qPCR. Deregulated miRNAs were studied using Diana Tools miRPath 3.0 to associate miRNA targets with molecular pathways. Microarray analysis identified 80 deregulated miRNAs (35 over-expressed and 45 under-expressed). Only miR-497-5p and miR-4417 maintained its deregulated expression after validation with qPCR. Among the molecular pathways in which deregulated miRNAs could be implicated, the most statistically significant pathway was ‘proteoglycans in cancer’. No relationship was found between miR-497-5p or miR-4417 expression and clinical or pathological parameters except of nodular affectation (high miR-4417 expression in patients with nodular affectation, p = 0.035) and radiotherapy (diminished miR-497-5p expression in patients who needed radiotherapy, p = 0.05). We have verified the altered expression of miR-497-5p and miR-4417 in Oral Squamous Cell Carcinoma samples and related the deregulated miRNAs with the ‘proteoglycans in cancer’ pathway.
Biology and Life Sciences, Biochemistry and Molecular Biology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
